Bank of America
VIVO

Bank of America’s Meridian Bioscience Inc VIVO Stock Holding History

Bank of America’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-118,438
Closed -$3.93M – 8638
2022
Q4 		$3.93M Buy
118,438
+44,767
+61% +$1.44M ﹤0.01% 3619
2022
Q3 		$2.32M Sell
73,671
-9,055
-11% -$293K ﹤0.01% 4130
2022
Q2 		$2.52M Buy
82,726
+11,957
+17% +$323K ﹤0.01% 4096
2022
Q1 		$1.84M Sell
70,769
-66,375
-48% -$1.58M ﹤0.01% 4673
2021
Q4 		$2.8M Buy
137,144
+91,730
+202% +$1.76M ﹤0.01% 4230
2021
Q3 		$873K Sell
45,414
-99,273
-69% -$1.98M ﹤0.01% 5203
2021
Q2 		$3.21M Sell
144,687
-4,042
-3% -$85.7K ﹤0.01% 3931
2021
Q1 		$3.9M Buy
148,729
+13,011
+10% +$309K ﹤0.01% 3645
2020
Q4 		$2.54M Buy
135,718
+32,468
+31% +$606K ﹤0.01% 3739
2020
Q3 		$1.75M Buy
103,250
+2,436
+2% +$47.3K ﹤0.01% 3782
2020
Q2 		$2.35M Buy
100,814
+63,473
+170% +$920K ﹤0.01% 3493
2020
Q1 		$314K Buy
37,341
+5,493
+17% +$46.2K ﹤0.01% 4823
2019
Q4 		$311K Sell
31,848
-46,575
-59% -$437K ﹤0.01% 5341
2019
Q3 		$744K Sell
78,423
-13,788
-15% -$145K ﹤0.01% 4782
2019
Q2 		$1.09M Buy
92,211
+12,953
+16% +$156K ﹤0.01% 4505
2019
Q1 		$1.4M Buy
79,258
+44,448
+128% +$739K ﹤0.01% 4271
2018
Q4 		$604K Buy
34,810
+21,649
+164% +$369K ﹤0.01% 4807
2018
Q3 		$196K Sell
13,161
-8,069
-38% -$125K ﹤0.01% 5492
2018
Q2 		$338K Sell
21,230
-14,712
-41% -$219K ﹤0.01% 5115
2018
Q1 		$511K Sell
35,942
-59,219
-62% -$876K ﹤0.01% 4796
2017
Q4 		$1.33M Sell
95,161
-10,756
-10% -$157K ﹤0.01% 4292
2017
Q3 		$1.51M Sell
105,917
-105,221
-50% -$1.5M ﹤0.01% 4210
2017
Q2 		$3.33M Buy
211,138
+89,433
+73% +$1.29M ﹤0.01% 3423
2017
Q1 		$1.68M Buy
121,705
+32,696
+37% +$457K ﹤0.01% 4020
2016
Q4 		$1.57M Buy
89,009
+21,000
+31% +$369K ﹤0.01% 3978
2016
Q3 		$1.31M Buy
68,009
+34,514
+103% +$675K ﹤0.01% 3962
2016
Q2 		$653K Sell
33,495
-6,798
-17% -$133K ﹤0.01% 4476
2016
Q1 		$831K Buy
40,293
+2,893
+8% +$57K ﹤0.01% 4232
2015
Q4 		$768K Sell
37,400
-3,557
-9% -$68.2K ﹤0.01% 4536
2015
Q3 		$701K Sell
40,957
-11,944
-23% -$218K ﹤0.01% 4577
2015
Q2 		$986K Buy
52,901
+39,235
+287% +$727K ﹤0.01% 4125
2015
Q1 		$261K Sell
13,666
-28,877
-68% -$534K ﹤0.01% 4760
2014
Q4 		$701K Buy
42,543
+28,405
+201% +$487K ﹤0.01% 4335
2014
Q3 		$250K Buy
14,138
+3,774
+36% +$74.1K ﹤0.01% 5191
2014
Q2 		$214K Sell
10,364
-27,007
-72% -$555K ﹤0.01% 5497
2014
Q1 		$814K Buy
37,371
+2,207
+6% +$50.6K ﹤0.01% 4126
2013
Q4 		$933K Buy
35,164
+2,183
+7% +$53.7K ﹤0.01% 4129
2013
Q3 		$780K Sell
32,981
-5,857
-15% -$137K ﹤0.01% 4199
2013
Q2 		$835K Buy
+38,838
New +$838K ﹤0.01% 4225

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's VIVO Position: Q1 2023 in Review

Bank of America sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 118,438 shares — an estimated $3.93M sold.

Bank of America first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $3.93M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Bank of America reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Bank of America sold 118,438 Meridian Bioscience Inc shares in Q1 2023, an estimated $3.93M.
  • Bank of America first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Bank of America's Meridian Bioscience Inc position peaked at $3.93M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.